GXMC
ELOS

Global X Management Company’s Syneron Medical Ltd ELOS Stock Holding History

Global X Management Company’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,991
Closed -$21K – 568
2014
Q2 		$21K Buy
+1,991
New +$21.5K ﹤0.01% 499

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Global X Management Company's ELOS Position: Q3 2014 in Review

Global X Management Company sold out of Syneron Medical Ltd (ELOS) in Q3 2014, closing a stake of 1,991 shares — an estimated $21K sold.

Global X Management Company first reported a position in ELOS in Q2 2014 and held it in 1 quarter. The position peaked at $21K in Q2 2014. 65 funds tracked by Wall St. Rank hold ELOS as of Q3 2014.

  • Global X Management Company reported no remaining Syneron Medical Ltd position as of Q3 2014 after selling out during the quarter.
  • Global X Management Company sold 1,991 Syneron Medical Ltd shares in Q3 2014, an estimated $21K.
  • Global X Management Company first reported a position in Syneron Medical Ltd in Q2 2014 and held it in 1 quarter.
  • Global X Management Company's Syneron Medical Ltd position peaked at $21K in Q2 2014.
  • 65 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2014.

Based on Global X Management Company's 13F filing for Q3 2014, filed 4 Nov 2014.